Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Debiopharm International SA
Acerta Pharma BV
University of Florida
Cellectar Biosciences, Inc.
Nuvation Bio Inc.
Essen Biotech
Mayo Clinic
Turning Point Therapeutics, Inc.
GlaxoSmithKline
Massive Bio, Inc.
Dana-Farber Cancer Institute
Incyte Corporation
AVM Biotechnology Inc
Virginia Commonwealth University
Incyte Corporation
City of Hope Medical Center